Biobehavioral research on nicotine use in women.
More American women are taking up smoking than men and fewer are quitting; if current trends continue, rates for women will surpass those for men by the mid-1990's. But ironically, much of what is known about the biobehavioural aspects of smoking is based on research using male subjects. The present paper reviews evidence suggesting that: (1) women may differ from men with regard to nicotine intake and/or effects; (2) nicotine intake and effects may be influenced by menstrual cycle phase; (3) oral contraceptive use and estrogen replacement therapy may affect intake and effects of nicotine; (4) the effects of chronic nicotine use on female reproductive endocrinology may have implications for the reinforcement of smoking; and (5) pharmacological agents used to treat smoking may have different effects in women than in men. Guidelines and suggestions are presented by future biobehavioural research in women, including standardization of assessment procedures, attention to the use of appropriate controls, and use of pharmacological probes.
Pomerleau
C S
CS
Behavioral Medicine Program, University of Michigan Department of Psychiatry, Ann Arbor 48105.
Pomerleau
O F
OF
Garcia
A W
AW
D001143:Arousal / Q000187:drug effects* / Q000502:physiology; D005260:Female; D006801:Humans; D008597:Menstrual Cycle / Q000187:drug effects* / Q000502:physiology; D008657:Metabolic Clearance Rate / Q000502:physiology; D009538:Nicotine / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics; D012737:Sex Factors; D012907:Smoking / Q000009:adverse effects / Q000503:physiopathology* / Q000523:psychology
D009538:Nicotine